White Paper: The Art Of Compliance - Turning Compliance Into A Sustainable Business Advantage

The last few years have presented extraordinary regulatory and quality compliance challenges for pharmaceutical, biotechnology, and medical device companies charged to do more with less as a result of consolidation, restructuring, and economic uncertainty. Without the right attention, these challenges can permit systems and processes to weaken, domain and critical thinking expertise to erode, and core quality principles to be neglected, leaving companies vulnerable to compliance lapses and enforcement action.

Companies can no longer afford to take a traditional compliance approach in this heightened regulatory environment. In the traditional compliance approach, Quality Assurance and Compliance are backroom cost centers, the internal police or "sales prevention" departments perceived as piling on non-value added requirements that detract from the company's ability to innovate and be profitable.